A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms

Experimental and Molecular Pathology

Volumn 83, Issue 3, 2007, Pages 480-483

  Bouaziz Borgi, Lobna ^a   Nguyen, Philipe ^b   Hezard, Nathalie ^b   Musharrafieh, Umayya ^c   Almawi, Wassim Y ^d   Mahjoub, Touhami ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b SERVICE DE DERMATOLOGIE   (France)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Deep venous thrombosis; Factor V; Single nucleotide polymorphisms

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; GENE MUTATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ACTIVATED PROTEIN C RESISTANCE; ADULT; CASE-CONTROL STUDIES; FACTOR V; GENE FREQUENCY; HAPLOTYPES; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 36049034636     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.04.006     Document Type: Article

References (23)

1. Alhenc-Gelas M., Nicaud V., Gandrille S., Van Dreden P., Amiral J., Aubury M.L., Fiessinger J.N., Emmerish J., and Aiach M. The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb. Haemost. 81 (1999) 193-197
2. Bertina R.M., Koeleman B.P., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., van der Velden P.A., and Reitsma P.H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
3. Bouaziz-Borgi L., Almawi W.Y., Mtiraoui N., Nsiri B., Keleshian S.H., Kreidy R., Louzir B., Hezard N., and Mahjoub T. Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon. Am. J. Hematol. 81 (2006) 641-643
4. Castaman G., Ruggeri M., Tosetto A., and Rodeghiero F. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and factor V Leiden mutation (R506Q) in factor V gene. Thromb. Haemost. 84 (2000) 3577-3578
5. Castaman G., Faioni E.M., Tosetto A., and Bernardi F. The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis. Haematologica 88 (2003) 1182-1189
6. Castoldi E., Rosing J., Girelli D., Hoekema L., Lunghi B., Mingozzi F., Ferraresi P., Friso S., Corrocher R., Tans G., and Bernardi F. Mutations in the R2 FV gene affect the ratio between the two FV isoforms in the plasma. Thromb. Haemost. 83 (2000) 362-365
7. Dahlbäck B. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Semin. Thromb. Hemost. 25 (1999) 273-289
8. de Visser M.C., Guasch J.F., Kamphuisen P.W., Vos H.L., Rosendaal F.R., and Bertina R.M. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis. Thromb. Haemost. 83 (2000) 577-582
9. Fainoi E.M., Franchi F., Bucciarelli P., Margalione M., De Stefano V., Castaman G., Finazzi G., and Mannucci P.M. Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of thromboembolism to carriers of factor V R506Q. Blood 94 (1999) 3062-3066
10. Faioni E.M., Castaman G., Asti D., Lussana F., and Rodeghiero F. Association of factor V deficiency with factor V HR2. Haematologica 89 (2004) 195-200
11. Folsom A.R., Cushman M., Tsai M.Y., Aleksic N., Heckbert S.R., Boland L.L., Tsai A.W., Yanez N.D., and Rosamond W.D. A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood 99 (2002) 2720-2725
12. Frere C., Saut N., Boukef M.K., Zili M., and Toumi N.E. Factor V Leiden G1691A and prothrombin G20210A mutations are common in Tunisia. J. Thromb. Haemost. 1 (2003) 2451-2452
13. Heit J.A. Risk factors for venous thromboembolism. Clin. Chest Med. 24 (2003) 1-12
14. Jadaon M.M., and Dashti A.A. HR2 haplotype in Arab population and patients with venous thrombosis in Kuwait. J. Thromb. Haemost. 3 (2005) 1467-1471
15. Luddington R., Jackson A., Pannerselvam S., Brown K., and Baglin T. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C. Thromb. Haemost. 83 (2000) 204-208
16. Luyendyk J.P., Tilley R.E., and Mackman N. Genetic susceptibility to thrombosis. Curr. Atheroscler. Rep. 8 (2006) 193-197
17. Margaglione M., Bossone A., Coalizzo D., D'Andrea G., Brancaccio V., Ciampa A., Grandone E., and Di M.G. FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile. Thromb. Haemost. 87 (2002) 32-36
18. Norstrom E., Thorelli E., and Dahlback B. Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood 100 (2002) 524-530
19. Pecheniuk N.M., Morris C.P., Walsh T.P., and Marsh N.A. The factor V HR2 haplotype: prevalence and association of the A4070G and A6755G polymorphisms. Blood Coagul. Fibrinolysis 12 (2001) 201-206
20. Rees D.C., Cox M., and Clegg J.B. World distribution of factor V Leiden. Lancet 346 (1995) 1133-1134
21. Tormene D., Fortuna S., Tognin G., Gavasso S., Pagnan A., Prandoni P., and Simioni P. The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study. J. Thromb. Haemost. 3 (2005) 1414-1420
22. Yanqing H., Fangping C., Qinzhi X., Zaifu J., Guangping W., Xiaoxia Z., Xiaoqun P., and Xiaobo N. No association between thrombosis and factor V gene polymorphisms in Chinese Han population. Thromb. Haemost. 89 (2003) 446-451
23. Zaatari G.S., Otrock Z.K., Sabbagh A.S., and Mahfouz R.A. Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese population. Pathology 38 (2006) 442-444